NYSE:HSP - Hospira Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$89.96 0.00 (0.00 %)
(As of 10/19/2018 04:00 PM ET)
Previous Close$89.96
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market Capitalization$15.56 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.

Receive HSP News and Ratings via Email

Sign-up to receive the latest news and ratings for HSP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
SymbolNYSE:HSP
CUSIP44106010
Phone+1-847-9376472

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins12.15%
Return on Equity16.51%
Return on Assets8.65%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$15.56 billion

Hospira (NYSE:HSP) Frequently Asked Questions

What is Hospira's stock symbol?

Hospira trades on the New York Stock Exchange (NYSE) under the ticker symbol "HSP."

How were Hospira's earnings last quarter?

Hospira, Inc. (NYSE:HSP) announced its earnings results on Wednesday, July, 29th. The healthcare company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.78 by $0.07. The healthcare company had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.18 billion. Hospira had a return on equity of 16.51% and a net margin of 12.15%. Hospira's revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.72 EPS. View Hospira's Earnings History.

How do I buy shares of Hospira?

Shares of HSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Hospira's stock price today?

One share of HSP stock can currently be purchased for approximately $89.96.

How big of a company is Hospira?

Hospira has a market capitalization of $15.56 billion.

What is Hospira's official website?

The official website for Hospira is http://www.hospira.com/.

How can I contact Hospira?

Hospira's mailing address is 275 N Field Dr, LAKE FOREST, IL 60045-2579, United States. The healthcare company can be reached via phone at +1-847-9376472.


MarketBeat Community Rating for Hospira (NYSE HSP)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  135 (Vote Outperform)
Underperform Votes:  237 (Vote Underperform)
Total Votes:  372
MarketBeat's community ratings are surveys of what our community members think about Hospira and other stocks. Vote "Outperform" if you believe HSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel